Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Amgen Inc.    AMGN

AMGEN INC.

(AMGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Latest news on AMGEN INC.
05/20AMGEN : Science, Execution, and COVID-19 Response Highlighted at Annual Stockhol..
PU
05/20AMGEN : Announces Voting Results Of Annual Meeting Of Stockholders
PR
05/20AMGEN INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/20AMGEN : Investor Insights Newsletter Q1 2020
PU
05/19AMGEN : Q4 2019 Financial Results
PU
05/15AMGEN INC. : Ex-dividend day for
FA
05/13AMGEN : Dancing and Kickboxing to Stay Fit Between Conference Calls
PU
05/13AMGEN : Showcases Oncology Pipeline At ASCO 2020
PR
05/12AMGEN : To Present At The Bank Of America Merrill Lynch Virtual Global Healthcar..
PR
05/12Lundbeck boosted by stockpiling, launches key drug remotely
RE
05/11AMGEN : Cytokinetics Shares Jump After FDA Fast Track Designation for Omecamtiv ..
DJ
05/08AMGEN : Cytokinetics Get Fast-Track Designation for Heart-Failure Treatment
DJ
05/08AMGEN : Comments On the Supreme Court of Japan Ruling On PCSK9 Patent Infringeme..
PU
05/06AMGEN INC : Entry into a Material Definitive Agreement, Financial Statements and..
AQ
05/06AMGEN : Otezla Shows Significant Improvements in Mild-to-Moderate Psoriasis
DJ
05/06AMGEN : Announces Positive Top-Line Results From Otezla® (apremilast) Phase 3 AD..
PR
05/05AMGEN : First Trial Decision Under Canada's Amended Patented Medicines (Notice O..
AQ
05/05AMGEN : Says Kyprolis Patents Upheld Against Generic Drug Maker Cipla
DJ
05/05AMGEN : KYPROLIS® (carfilzomib) Patents Upheld Against Generic Manufacturer
PR
05/04AMGEN : To Present At The SunTrust Robinson Humphrey Life Sciences Summit Virtua..
PR
05/01AMGEN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS ..
AQ
04/30ADAPTIVE BIOTECHNOLOGIES : Amgen studying Otezla for coronavirus, looking into o..
RE
04/30AMGEN : Posts Lower 1Q Profit as Research and Development Expenses Rise
DJ
04/30AMGEN : 1Q Earnings Snapshot
AQ
04/30AMGEN INC : Results of Operations and Financial Condition, Financial Statements ..
AQ
04/30AMGEN : Reports First Quarter 2020 Financial Results
PR
04/30GLOBAL MARKETS LIVE: Another batch of earnings reports
04/29AMGEN : First Trial Judgment Under New PMNOC Regulations Declares Claims To Biol..
AQ
04/28AMGEN : “Now More Than Ever, We Need to Lean In”
PU
04/28AMGEN : Giving to Our Most Vulnerable Populations
PU
04/27AMGEN : Ireland Research Scientist Volunteers to Help Develop New COVID-19 Diagn..
PU
04/27AMGEN : New Programs Deliver Investigational Medicines to Patients' Homes
PU
04/27AMGEN : Announces Webcast Of 2020 First Quarter Financial Results
PR
04/27AMGEN INC. : quaterly earnings release
04/24AMGEN : “We're Gaining Ground Fast”
PU
04/24AMGEN : On DNA Day, A Salute to the “Magic” Genes That Give Us a Fig..
PU
04/22AMGEN : Highlights from Amgen and Adaptive Biotechnologies Webinar on Research t..
PU
04/22MorphoSys Appoints Roland Wandeler, Ph.D., as Chief Commercial Officer
AQ
04/15AMGEN : How Amgen Continues to Foster Inclusion and Belonging During COVID-19
PU
04/15AMGEN : A Sea Change in Drug Design
PU
04/07AMGEN : Can Therapeutic Antibodies Offer Hope for COVID-19 Patients?
PU
04/07AMGEN : And Adaptive Biotechnologies To Participate In Webinar On COVID-19 Strat..
PR
04/02NEWS HIGHLIGHTS : Top Company News of the Day
DJ
04/02NEWS HIGHLIGHTS : Top Company News of the Day
DJ
04/02NEWS HIGHLIGHTS : Top Company News of the Day
DJ
04/02NEWS HIGHLIGHTS : Top Company News of the Day
DJ
04/02AMGEN : And Adaptive Biotechnologies Announce Strategic Partnership To Develop A..
PR
03/31AMGEN : Establishes Wholly-Owned Affiliate In Japan
PR
03/31AMGEN : 2019 Letter to Shareholders
PU
03/31AMGEN : Update Regarding COVID-19 For Media
PU
03/31AMGEN INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-..
AQ
03/23AMGEN : Update Regarding COVID-19 For Media
PU
03/23AMGEN : And The Amgen : Foundation Commit Up To $12.5 Million To Support COVID-1..
PR
03/20AMGEN : R&D Head Dr. David Reese Shares Perspective on COVID-19
PU
03/17AMGEN : Update Regarding COVID-19 For Media
PU
03/16Pharmaceutical Firms Curtailing In-Person Sales Calls to Doctors
DJ
03/16Pharmaceutical Firms Curtailing In-Person Sales Calls to Doctors
DJ
03/13AMGEN : Update Regarding COVID-19
PU
03/11AMGEN : Update Regarding COVID-19
PU
03/06AMGEN : Update Regarding COVID-19
PU
03/05AMGEN : Update Regarding COVID-19
PU
03/04AMGEN : Announces 2020 Second Quarter Dividend
PR
03/02AMGEN : to Present at the Cowen 40th Annual Healthcare Conference
AQ
03/02KARYOPHARM THERAPEUTICS : Appoints Richard Paulson to its Board of Directors
AQ
02/27AMGEN : To Present At The Cowen 40th Annual Healthcare Conference
PR
02/26Amgen Shares Up, Will Continue Phase 3 Heart Failure Trial
DJ
02/26AMGEN : Cytokinetics to Continue Phase 3 Heart Failure Trial
DJ
02/21AMGEN INC : Entry into a Material Definitive Agreement, Financial Statements and..
AQ
02/21Pharmaceutical companies develop system to better track counterfeit drugs
RE
02/19AMGEN : Investor Insights Newsletter Q4 2019
PU
02/13AMGEN : Ex-dividend day for
FA
02/12AMGEN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS ..
AQ
02/11AMGEN : How Two Female Staff Members Found a Career in Science
PU
02/06AMGEN : Survivors in Canada are Taking Steps to Reduce the Risk of Another Heart..
AQ
02/04AMGEN : Staff Share Their Commitment to Cancer Research for World Cancer Day
PU
1  2  3  4  5  6  7  8  9  10Next